Theragenics Corporation

Theragenics Corporation operates as a medical device company serving the cancer treatment and surgical markets. The company operates through two segments, Brachytherapy Seed and Surgical Products. The Brachytherapy segment produces, markets, and sells TheraSeed, a cancer treatment device; I-Seed, an iodine-125 based prostate cancer treatment device; and related products and services. The Surgical Products segment offers wound closure and vascular access products, including sutures, needles, strips and tape, glues and other surgical sealants, and other surgical products for urology, veterinary, cardiology, orthopedics, plastic surgery, and dental applications. It also offers introducers and guide wires used in the interventional radiology and cardiology, and vascular surgery markets. The company sells its products through third-party distributors and directly to physicians, hospitals, and other healthcare providers in the United States, Canada, Puerto Rico, and internationally. Theragenics Corporation was founded in 1981 and is based in Buford, Georgia.